Magic mushrooms offered at Harley St clinic
And other stories from the stranger side of life

A Harley Street clinic is to offer “welcoming setting” for adults to listen to music while taking drugs such as magic mushrooms, LSD, ketamine and MDMA, according to The Times. The centre will provide Europe’s first commercial setting for clinical trials of psychedelic drugs when it opens this summer. A study by Imperial College London found that psilocybin, the active ingredient in magic mushrooms, is more effective than antidepressants when offered with therapy.
Dead man wins Texan election
Residents of a city in Texas have voted to keep their mayor in power despite him having recently died. Ramiro Rodriguez Jr. beat Israel Silva in Palmhurst on Saturday after he received 329 votes to his rival’s 234. Rodriguez Jr. had held the position from 1999 until his death on April 5, but his name remained on the ballot. A fresh election will now need to be held to elect a new mayor.
‘Senior fitizens’ on the rise in UK
The UK is experiencing the rise of the “senior fitizen”, said The Telegraph. A new Global State of Mind report by fitness brand Asics found that the biggest growth area for exercise is among people between the ages of 57 and 70. Meanwhile, Sport England’s recent Active Lives Survey found that fitness activity among those aged 55 to 74 and 75 plus is now returning to near pre-pandemic numbers. PureGym has also reported a 14% increase in the number of over-60s in its membership base compared with before the pandemic.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
A running list of RFK Jr.'s controversies
In Depth The man atop the Department of Health and Human Services has had no shortage of scandals over the years
By Brigid Kennedy
-
Film reviews: Sinners and The King of Kings
Feature Vampires lay siege to a Mississippi juke joint and an animated retelling of Jesus' life
By The Week US
-
Music reviews: Bon Iver, Valerie June, and The Waterboys
Feature "Sable, Fable," "Owls, Omens, and Oracles," "Life, Death, and Dennis Hopper"
By The Week US
-
Why Russia removed the Taliban's terrorist designation
The Explainer Russia had designated the Taliban as a terrorist group over 20 years ago
By Justin Klawans, The Week US
-
Inside the Israel-Turkey geopolitical dance across Syria
THE EXPLAINER As Syria struggles in the wake of the Assad regime's collapse, its neighbors are carefully coordinating to avoid potential military confrontations
By Rafi Schwartz, The Week US
-
'Like a sound from hell': Serbia and sonic weapons
The Explainer Half a million people sign petition alleging Serbian police used an illegal 'sound cannon' to disrupt anti-government protests
By Abby Wilson
-
The arrest of the Philippines' former president leaves the country's drug war in disarray
In the Spotlight Rodrigo Duterte was arrested by the ICC earlier this month
By Justin Klawans, The Week US
-
Ukrainian election: who could replace Zelenskyy?
The Explainer Donald Trump's 'dictator' jibe raises pressure on Ukraine to the polls while the country is under martial law
By Sorcha Bradley, The Week UK
-
Why Serbian protesters set off smoke bombs in parliament
THE EXPLAINER Ongoing anti-corruption protests erupted into full view this week as Serbian protesters threw the country's legislature into chaos
By Rafi Schwartz, The Week US
-
Who is the Hat Man? 'Shadow people' and sleep paralysis
In Depth 'Sleep demons' have plagued our dreams throughout the centuries, but the explanation could be medical
By The Week Staff
-
Assad's fall upends the Captagon drug empire
Multi-billion-dollar drug network sustained former Syrian regime
By Richard Windsor, The Week UK